FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313784182> ?p ?o ?g. }

• W4313784182 endingPage "108" @default.
• W4313784182 startingPage "98" @default.
• W4313784182 abstract "Introduction . A combination of antiandrogen and cytostatic drugs was justified in the neoadjuvant therapy of patients with high-risk prostate cancer (HiRPCa) in some clinical trials. The effectiveness of such therapy in each individual case depends on the sensitivity of cancer cells to the applied drugs. It makes possible the development of the new technologies to personalize therapeutic approach. MicroRNAs (miRNAs) are a class of regulatory molecules whose expression is altered in PCa cells and can be associated with the sensitivity/resistance of cancer cells to specific cytostatics, for instance, taxanes. Objective . To identify the potential-marker miRNAs of PCa cells sensitivity to taxanes. Materials and methods . Samples of PCa tissue (n. 56) obtained from patients underwent neo-adjuvant therapy (antiandrogen and taxanes) and radical prostatectomy; PCa cell lines (PC-3, DU-145, LNCap). Total RNAs isolation was carried out using miRNeasy FFPE Kit, LRU-100-50; miRCURY LNA miRNA Focus PCR Panel, All-MIR kits were used for semi-quantitative analysis of potentially marker microRNA molecules using sequential reverse transcription and PCR. Results . The effect of taxanes on PCa cells is associated with up-regulation of miR-106b expression and down-regulation of miR-200c expression in both in vivo and in vitro conditions. Conclusion . MiR-106b and miR-200c miRNAs are involved in the response of PCa cells to taxanes, and therapeutic modification of these molecules in PCa cells may present a potential strategy to increase their sensitivity to taxane-containing therapy. Appropriate innovative technology may be in demand in the treatment of HiRPCa-patients." @default.
• W4313784182 created "2023-01-08" @default.
• W4313784182 creator A5013640746 @default.
• W4313784182 creator A5015353396 @default.
• W4313784182 creator A5015454367 @default.
• W4313784182 creator A5031960406 @default.
• W4313784182 creator A5039219106 @default.
• W4313784182 creator A5049520048 @default.
• W4313784182 creator A5059724602 @default.
• W4313784182 creator A5084673066 @default.
• W4313784182 creator A5088702643 @default.
• W4313784182 date "2022-12-26" @default.
• W4313784182 modified "2023-10-10" @default.
• W4313784182 title "Effect of taxanes on the miR-106 and miR-200c expression in prostate cancer cells in vivo and in vitro" @default.
• W4313784182 cites W2006760747 @default.
• W4313784182 cites W2044512288 @default.
• W4313784182 cites W2064590153 @default.
• W4313784182 cites W2066305227 @default.
• W4313784182 cites W2079113237 @default.
• W4313784182 cites W2088246882 @default.
• W4313784182 cites W2213723834 @default.
• W4313784182 cites W2333330203 @default.
• W4313784182 cites W2556619639 @default.
• W4313784182 cites W2569736996 @default.
• W4313784182 cites W2763467492 @default.
• W4313784182 cites W2767902504 @default.
• W4313784182 cites W2787731732 @default.
• W4313784182 cites W2790212419 @default.
• W4313784182 cites W2887043249 @default.
• W4313784182 cites W2893643118 @default.
• W4313784182 cites W2948027196 @default.
• W4313784182 cites W2980186852 @default.
• W4313784182 cites W2999207890 @default.
• W4313784182 cites W3003681551 @default.
• W4313784182 cites W3019399624 @default.
• W4313784182 cites W3024218490 @default.
• W4313784182 cites W3030245734 @default.
• W4313784182 cites W3040059733 @default.
• W4313784182 cites W3129805177 @default.
• W4313784182 cites W3136136801 @default.
• W4313784182 cites W3163897593 @default.
• W4313784182 cites W3180822691 @default.
• W4313784182 cites W4236100992 @default.
• W4313784182 doi "https://doi.org/10.21886/2308-6424-2022-10-4-98-108" @default.
• W4313784182 hasPublicationYear "2022" @default.
• W4313784182 type Work @default.
• W4313784182 citedByCount "1" @default.
• W4313784182 crossrefType "journal-article" @default.
• W4313784182 hasAuthorship W4313784182A5013640746 @default.
• W4313784182 hasAuthorship W4313784182A5015353396 @default.
• W4313784182 hasAuthorship W4313784182A5015454367 @default.
• W4313784182 hasAuthorship W4313784182A5031960406 @default.
• W4313784182 hasAuthorship W4313784182A5039219106 @default.
• W4313784182 hasAuthorship W4313784182A5049520048 @default.
• W4313784182 hasAuthorship W4313784182A5059724602 @default.
• W4313784182 hasAuthorship W4313784182A5084673066 @default.
• W4313784182 hasAuthorship W4313784182A5088702643 @default.
• W4313784182 hasBestOaLocation W43137841821 @default.
• W4313784182 hasConcept C104317684 @default.
• W4313784182 hasConcept C121608353 @default.
• W4313784182 hasConcept C126322002 @default.
• W4313784182 hasConcept C143998085 @default.
• W4313784182 hasConcept C145059251 @default.
• W4313784182 hasConcept C150903083 @default.
• W4313784182 hasConcept C207001950 @default.
• W4313784182 hasConcept C2777511904 @default.
• W4313784182 hasConcept C2779723316 @default.
• W4313784182 hasConcept C2780192828 @default.
• W4313784182 hasConcept C502942594 @default.
• W4313784182 hasConcept C530470458 @default.
• W4313784182 hasConcept C55493867 @default.
• W4313784182 hasConcept C71924100 @default.
• W4313784182 hasConcept C86803240 @default.
• W4313784182 hasConceptScore W4313784182C104317684 @default.
• W4313784182 hasConceptScore W4313784182C121608353 @default.
• W4313784182 hasConceptScore W4313784182C126322002 @default.
• W4313784182 hasConceptScore W4313784182C143998085 @default.
• W4313784182 hasConceptScore W4313784182C145059251 @default.
• W4313784182 hasConceptScore W4313784182C150903083 @default.
• W4313784182 hasConceptScore W4313784182C207001950 @default.
• W4313784182 hasConceptScore W4313784182C2777511904 @default.
• W4313784182 hasConceptScore W4313784182C2779723316 @default.
• W4313784182 hasConceptScore W4313784182C2780192828 @default.
• W4313784182 hasConceptScore W4313784182C502942594 @default.
• W4313784182 hasConceptScore W4313784182C530470458 @default.
• W4313784182 hasConceptScore W4313784182C55493867 @default.
• W4313784182 hasConceptScore W4313784182C71924100 @default.
• W4313784182 hasConceptScore W4313784182C86803240 @default.
• W4313784182 hasIssue "4" @default.
• W4313784182 hasLocation W43137841821 @default.
• W4313784182 hasOpenAccess W4313784182 @default.
• W4313784182 hasPrimaryLocation W43137841821 @default.
• W4313784182 hasRelatedWork W1653340856 @default.
• W4313784182 hasRelatedWork W2014434161 @default.
• W4313784182 hasRelatedWork W2094570582 @default.
• W4313784182 hasRelatedWork W2115093090 @default.
• W4313784182 hasRelatedWork W2118642421 @default.
• W4313784182 hasRelatedWork W2327416075 @default.

• next